189 related articles for article (PubMed ID: 2766464)
21. Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters.
Neveu MJ; Babcock KL; Hertzberg EL; Paul DL; Nicholson BJ; Pitot HC
Cancer Res; 1994 Jun; 54(12):3145-52. PubMed ID: 8205533
[TBL] [Abstract][Full Text] [Related]
22. Effect of the age of B6C3F1 mice on phenobarbital promotion of diethylnitrosamine-initiated liver tumors.
Klaunig JE; Weghorst CM; Pereira MA
Toxicol Appl Pharmacol; 1987 Aug; 90(1):79-85. PubMed ID: 3629593
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of the paradoxical, inhibitory effect of phenobarbital on hepatocarcinogenesis initiated in infant B6C3F1 mice with diethylnitrosamine.
Lee GH; Ooasa T; Osanai M
Cancer Res; 1998 Apr; 58(8):1665-9. PubMed ID: 9563480
[TBL] [Abstract][Full Text] [Related]
24. Tumor promoting activities of ethylphenylacetylurea and diethylacetylurea, the ring hydrolysis products of barbiturate tumor promoters phenobarbital and barbital, in rat liver and kidney initiated by N-nitrosodiethylamine.
Diwan BA; Nims RW; Ward JM; Hu H; Lubet RA; Rice JM
Carcinogenesis; 1989 Jan; 10(1):189-94. PubMed ID: 2910522
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.
Bursch W; Chabicovsky M; Wastl U; Grasl-Kraupp B; Bukowska K; Taper H; Schulte-Hermann R
Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704
[TBL] [Abstract][Full Text] [Related]
26. Comparison in C3H and C3B6F1 mice of the sensitivity to diethylnitrosamine-initiation and phenobarbital-promotion to the extent of cell proliferation.
Pereira MA
Carcinogenesis; 1993 Feb; 14(2):299-302. PubMed ID: 8382116
[TBL] [Abstract][Full Text] [Related]
27. Effect of phenobarbital on diethylnitrosamine and dimethylnitrosamine induced hepatocellular tumors in male B6C3F1 mice.
Klaunig JE; Weghorst CM; Pereira MA
Cancer Lett; 1988; 42(1-2):133-9. PubMed ID: 3180032
[TBL] [Abstract][Full Text] [Related]
28. Further evidence for promoter-dependent development of hepatoblastoma in the mouse.
Diwan BA; Henneman JR; Rice JM
Cancer Lett; 1995 Feb; 89(1):29-35. PubMed ID: 7882299
[TBL] [Abstract][Full Text] [Related]
29. Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions.
Wastl UM; Rossmanith W; Lang MA; Camus-Randon AM; Grasl-Kraupp B; Bursch W; Schulte-Hermann R
Mol Carcinog; 1998 Aug; 22(4):229-34. PubMed ID: 9726815
[TBL] [Abstract][Full Text] [Related]
30. Inhibition by phenobarbital and lack of effect of amobarbital on the development of liver tumors induced by N-nitrosodiethylamine in juvenile B6C3F1 mice.
Diwan BA; Rice JM; Ward JM; Ohshima M; Lynch PH
Cancer Lett; 1984 Jun; 23(2):223-34. PubMed ID: 6744246
[TBL] [Abstract][Full Text] [Related]
31. Promotion of preneoplastic lesions and induction of CYP2B by unleaded gasoline vapor in female B6C3F1 mouse liver.
Standeven AM; Goldsworthy TL
Carcinogenesis; 1993 Oct; 14(10):2137-41. PubMed ID: 8222067
[TBL] [Abstract][Full Text] [Related]
32. Dissimilar frequency of hepatoblastomas and hepatic cystadenomas and adenocarcinomas arising in hepatocellular neoplasms of D2B6F1 mice initiated with N-nitrosodiethylamine and subsequently given Aroclor-1254, dichlorodiphenyltrichloroethane, or phenobarbital.
Diwan BA; Ward JM; Kurata Y; Rice JM
Toxicol Pathol; 1994; 22(4):430-9. PubMed ID: 7817132
[TBL] [Abstract][Full Text] [Related]
33. Methyl tertiary butyl ether lacks tumor-promoting activity in N-nitrosodiethylamine-initiated B6C3F1 female mouse liver.
Moser GJ; Wong BA; Wolf DC; Fransson-Steen RL; Goldsworthy TL
Carcinogenesis; 1996 Dec; 17(12):2753-61. PubMed ID: 9006116
[TBL] [Abstract][Full Text] [Related]
34. Loss of tumor-promoting activity of unleaded gasoline in N-nitrosodiethylamine-initiated ovariectomized B6C3F1 mouse liver.
Moser GJ; Wolf DC; Wong BA; Goldsworthy TL
Carcinogenesis; 1997 May; 18(5):1075-83. PubMed ID: 9163699
[TBL] [Abstract][Full Text] [Related]
35. Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen.
Rignall B; Braeuning A; Buchmann A; Schwarz M
Carcinogenesis; 2011 Jan; 32(1):52-7. PubMed ID: 21047994
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility to phenobarbital promotion of hepatotumorigenesis: correlation with differential expression and induction of hepatic drug metabolizing enzymes in heavy and light male (C3H x VY) F1 hybrid mice.
Wolff GL; Leakey JE; Bazare JJ; Harmon JR; Webb PJ; Law MG
Carcinogenesis; 1991 May; 12(5):911-5. PubMed ID: 1674234
[TBL] [Abstract][Full Text] [Related]
37. Suppression of altered hepatic foci development by a high fish oil diet compared with a high corn oil diet in rats.
Lii CK; Ou CC; Liu KL; Liu JY; Lin WL; Chen HW
Nutr Cancer; 2000; 38(1):50-9. PubMed ID: 11341044
[TBL] [Abstract][Full Text] [Related]
38. Presence of alpha-fetoprotein-positive cells in hepatocellular foci and microcarcinomas induced by single injections of diethylnitrosamine in infant mice.
Koen H; Pugh TD; Nychka D; Goldfarb S
Cancer Res; 1983 Feb; 43(2):702-8. PubMed ID: 6184154
[TBL] [Abstract][Full Text] [Related]
39. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
Moser GJ; Wolf DC; Goldsworthy TL
Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of fat-related modulation of N-nitrosodiethylamine-induced tumors in rats: organ distribution, blood lipids, enzymes and pro-oxidant state.
Hietanen E; Bartsch H; Ahotupa M; Béréziat JC; Bussacchini-Griot V; Cabral JR; Camus AM; Laitinen M; Wild H
Carcinogenesis; 1991 Apr; 12(4):591-600. PubMed ID: 1672840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
